Nutri Shark
Natural health product licensed in Canada
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80056569
- Status
- Active licence
- Licence date
- 16 December 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cartilage de requin Source : Cartilage de requin Potency : 75 mg Calcium | 750 mg | Not calculated |
Non-medicinal ingredients
Phosphate dicalcique, Cellulose microcristalline, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
A natural source of Calcium for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner prior to use if you are pregnant and/or breastfeeding. Some people may experience gastrointestinal disturbances (eg. bloating, abdominal cramps, etc); in which case, discontinue use. Consult a health care practitioner prior to use if you have recently had a heart attack, surgery, or a major accident.
- Effets indésirables connus
Orally, shark cartilage can cause taste disturbances, nausea, vomiting, dyspepsia, constipation, hypotension, dizziness, hyperglycemia, hypoglycemia, hypercalcemia, altered consciousness, decreased motor strength, decreased sensation, erythema, peripheral edema, generalized weakness, fatigue, and decreased performance, in which case discontinue use and consult a health care practitioner. It might also cause signs of acute hepatitis, including low-grade fever, jaundice, yellowing of eyes, right upper quadrant tenderness, and elevated liver enzymes; in which case, discontinue use and consult a health care practitioner. Theoretically, concomitant use with supplemental calcium might exacerbate hypercalcemia; in which case, discontinue use and consult a health care practitioner. Hypersensitivity (eg. allergy) to shark cartilage or any of its ingredients including glucosamine and chondroitin has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80056569
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.